PF-07321332, molecular model. The image shows the structure of PF-07321332, an antiviral drug developed by Pfizer which acts as a protease inhibitor in the treatment of COVID-19. In order to slow down the metabolism of PF-07321332, Ritonavir is added. As of 2021, the combination of PF-07321332 and Ritonavir is in phase II trials under the name Paxlovid. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Laguna Design |
Taille de l’image : | 5000 px × 3750 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |